Fast-acting approaches for treatment-resistant depression: real-world comparative effectiveness of Intranasal Esketamine versus accelerated rTMS.
Michele Prato, Matteo Carminati, Filippo Frizzi, Greta Verri, Mattia Tondello, Barbara Barbini, Cristina Colombo, Zanardi Raffaella
Int J Psychiatry Clin Pract March 11, 2026 DOI: 10.1080/13651501.2026.2642680 (opens in new tab)
Study at a glance
AI-extracted from the abstract| Characteristics | Observational cohort Peer reviewed |
|---|---|
| Population | Patients with treatment-resistant depression |
| Interventions | Intranasal Esketamine accelerated rTMS |
| Topics | Depression Esketamine |
| Citations | 1 |
| Key findings | Intranasal esketamine and accelerated rTMS showed comparable real-world effectiveness for treatment-resistant depression. |
Abstract
Fast-acting approaches for treatment-resistant depression: real-world comparative effectiveness of Intranasal Esketamine versus accelerated rTMS.